Results 221 to 230 of about 3,079 (276)

Clinical utility of telomeres as diagnostic and short-term prognostic markers in loco-regional treatment of hepatocellular carcinoma. [PDF]

World J Gastroenterol
El-Nakeep S, AbdelAziz H, Michael TG, ElGhandour AM, Abdelsattar HA, Awad FMR, Kasi A.   +6 more
europepmc   +1 more source

Systemic Therapy for Advanced Hepatocellular Carcinoma in 2026: Current Standard‐of‐Care and Emerging Therapeutic Strategies

Journal of Gastroenterology and Hepatology, Volume 41, Issue 5, Page 1436-1445, May 2026.
ABSTRACT Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, accounting for up to 80% of all cases. Most patients present at an advanced stage and are unsuitable for curative treatments. In the past 5 years, immunotherapy combination has superseded tyrosine kinase inhibitors (TKI) as the standard first‐line therapy for ...
Landon L. Chan, Kallista O. K. Chan, Stephen L. Chan   +2 more
wiley   +1 more source

The combination of anti-PD-1 antibodies, trastuzumab and chemotherapy may improve the outcome of some patients with HER2-positive alpha-fetoprotein-producing gastric cancer: a retrospective real-world analysis from a single center. [PDF]

BMC Cancer
Ge S, Wang F, Li H, Yang Y, Zhang L, Duan J, Bai M, Liu R, Ning T, Wang X, Ji Z, Sun Y, Deng T.   +12 more
europepmc   +1 more source

[Conversion therapy for hepatoid adenocarcinoma of the stomach: A case report]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Li J, Chen L, Tang J, Wu Y, Wang A.
europepmc   +1 more source

Primary hepatic alpha-fetoprotein-producing neuroendocrine neoplasm harboring FGFR2 and TP53 mutations: a case report and literature review. [PDF]

Med Mol Morphol
Watanabe H, Enda K, Fujishima F, Shirota H, Ninomiya M, Yamazaki T, Sasano H, Suzuki T.   +7 more
europepmc   +1 more source

Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinoma. [PDF]

World J Gastroenterol
Villa E, Donghia R, Coletta S, Bonfiglio C, Critelli RM, Ancona A, Shahini E, Iacovazzi PA, Cozzolongo R, Pavone F, Carella N, Pontisso P, Martini A, Al Aoua S, Bantel H, Giannelli G.   +15 more
europepmc   +1 more source

Refining surveillance of hepatocellular carcinoma in chronic hepatitis B through biomarker-based risk stratification. [PDF]

Hepatol Commun
Tseng TC, Huang SC, Kao JH.
europepmc   +1 more source

Serum Mac-2 binding protein glycosylation isomer in predicting hepatocellular carcinoma occurrence among patients with direct-acting antiviral-induced HCV cure. [PDF]

Sci Rep
Chang YP, Chen YC, Su TH, Huang SC, Tseng TC, Chen PJ, Liu CJ, Kao JH, Liu CH.   +8 more
europepmc   +1 more source

Serum alpha fetoprotein in childhood.

The Turkish journal of pediatrics, 1973
A I Berkel, F Ersoy, N Cevik, N Koçak
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Alpha-fetoprotein

American Journal of Obstetrics and Gynecology, 1976
Despite all the information about AFP presented, a great deal still needs to be discovered especially in pregnancy. Geographical and racial differences remain to be elucidated. Similarly, differences in obstetric population in Helsinki and Baltimore, for example, are only now being studied. Sex differences may exist; Lardinois and associates195 cited a
H L, Lau, S E, Linkins
  +6 more sources